paper-with-me

Papers

Explainable Graph-theoretical Machine Learning: with Application to Alzheimer's Disease Prediction

2025-03-20 · Narmina Baghirova, Duy-Thanh Vũ, Duy-Cat Can, Christelle Schneuwly Diaz, Julien Bodlet, Guillaume Blanc, Georgi Hrusanov, Bernard Ries, Oliver Y. Chén

Alzheimer's disease (AD) affects 50 million people worldwide and is projected to overwhelm 152 million by 2050. AD is characterized by cognitive decline due partly to disruptions in metabolic brain connectivity. Thus, early and accurate detection of metabolic brain network impairments is crucial for AD management. Chief to identifying such impairments is FDG-PET data. Despite advancements, most graph-based studies using FDG-PET data rely on group-level analysis or thresholding. Yet, group-level analysis can veil individual differences and thresholding may overlook weaker but biologically critical brain connections. Additionally, machine learning-based AD prediction largely focuses on univariate outcomes, such as disease status. Here, we introduce explainable graph-theoretical machine learning (XGML), a framework employing kernel density estimation and dynamic time warping to construct individual metabolic brain graphs that capture the distance between pair-wise brain regions and identify subgraphs most predictive of multivariate AD-related outcomes. Using FDG-PET data from the Alzheimer's Disease Neuroimaging Initiative, XGML builds metabolic brain graphs and uncovers subgraphs predictive of eight AD-related cognitive scores in new subjects. XGML shows robust performance, particularly for predicting scores measuring learning, memory, language, praxis, and orientation, such as CDRSB ($r = 0.74$), ADAS11 ($r = 0.73$), and ADAS13 ($r = 0.71$). Moreover, XGML unveils key edges jointly but differentially predictive of several AD-related outcomes; they may serve as potential network biomarkers for assessing overall cognitive decline. Together, we show the promise of graph-theoretical machine learning in biomarker discovery and disease prediction and its potential to improve our understanding of network neural mechanisms underlying AD.

📄 PDF Abstract BibTeX arXiv:2503.16286

Code (0)

등록된 구현이 없습니다.

Tasks

Density EstimationDisease PredictionDynamic Time Warping

Similar Papers 제목 키워드 기반

Flexible and Explainable Graph Analysis for EEG-based Alzheimer's Disease Classification

2025-04-02 · Jing Wang, Jun-En Ding, Feng Liu, Elisa Kallioniemi 외

Alzheimer's Disease is a progressive neurological disorder that is one of the most common forms of dementia. It leads to a decline in memory, reasoning ability, and behavior, especially in older people. The cause of Alzh…

EEGSpecificity

Understanding Alzheimer disease’s structural connectivity through explainable AI

2020-01-25 · MIDL 2019 7 · Achraf Essemlali, Etienne St-Onge, Jean Christophe Houde, Pierre Marc Jodoin 외

In the following work, we use a modified version of deep BrainNet convolutional neural network (CNN) trained on the diffusion weighted MRI (DW-MRI) tractography connectomes of patients with Alzheimer’s Disease (AD) and M…

Diffusion MRI

Adaptive Gated Graph Convolutional Network for Explainable Diagnosis of Alzheimer's Disease using EEG Data

2023-04-12 · Dominik Klepl, Fei He, Min Wu, Daniel J. Blackburn 외

Graph neural network (GNN) models are increasingly being used for the classification of electroencephalography (EEG) data. However, GNN-based diagnosis of neurological disorders, such as Alzheimer's disease (AD), remains…

EEGFunctional ConnectivityGraph Neural Network

Explainable Graph Neural Networks: Understanding Brain Connectivity and Biomarkers in Dementia

2025-09-23 · Niharika Tewari, Nguyen Linh Dan Le, Mujie Liu, Jing Ren 외 arxiv

Dementia is a progressive neurodegenerative disorder with multiple etiologies, including Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and vascular dementia. Its clinical and biological heterogeneity…

Early Detection of Alzheimer's Disease Using Explainable Machine Learning on Clinical Biomarkers: A Multi-Class Classification Study Using the Alzheimer's Disease Neuroimaging Initiative (ADNI) Dataset

2026-04-14 · Afshan Hashmi arxiv

Background: Alzheimer's disease (AD) affects over 55 million people worldwide. Accurate, interpretable detection of normal cognition (NC), mild cognitive impairment (MCI), and AD from routine clinical assessments remains…

Multi-class ClassificationFeature Importance